[The use of decision making analysis for evaluating hepatitis B inoculation strategy].
Using quality adjusted life year (QALY) as an evaluation measure of cost-effectiveness for assessing hepatitis B inoculation strategy in China, through the decision tree model. The result showed that for hepatitis B inoculation, priority should be given to neonates and infants aged 0-3 years; and the age of vaccination subjects be extended to, adults older than 25 yrs. The result also indicated: that the net cost for each QALY gained due to vaccination was very high, so that the ultimate control of hepatitis B epidemic not only depended on the development of highly effective and inexpensive vaccine, but also on the improvement of economic level and sanitary status.
Zhuang
G H
GH
Department of Epidemiology, Xi'an Medical University.
Xu
H W
HW
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D002648:Child; D002675:Child, Preschool; D003362:Cost-Benefit Analysis; D003657:Decision Making; D003663:Decision Trees; D005260:Female; D006509:Hepatitis B / Q000517:prevention & control*; D017325:Hepatitis B Vaccines / Q000191:economics*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D015993:Life Tables; D008297:Male; D014611:Vaccination / Q000191:economics*
D017325:Hepatitis B Vaccines